Forecast upgrade for EKF

Acquiring Advanced Diagnostics Laboratory (ADL) has sparked a substantial upgrade for EKF Diagnostics (LON: EKF).

ADL is a Texas-based PCR-focused testing laboratory operator. It is certified under the Clinical Laboratory Improvement Amendments (CLIA) for complex testing. The deal costs an initial $10m in shares. Performance-based consideration could be payable over three years. This is capped at $60m.

This is a new business that was founded in May 2020, but it does have an experienced ma...

You are unauthorized to view this page.

Latest News

More Articles Like This

Tagdiv Cloud library - template content.